Is Tylenol the hidden cause of autism? Trump and RFK Jr. ignite the debate

In the United States, the administration of Donald Trump, together with Secretary of Health Robert F. Kennedy Jr., is preparing to release an important statement regarding autism. This is an issue that has attracted significant attention for years and carries strong scientific, political, and emotional weight.

The upcoming announcement is expected to focus on two main points: a warning about the use of the drug Tylenol (acetaminophen) by pregnant women, and a suggestion regarding the use of leucovorin as a potential treatment for certain autism symptoms.

According to media reports such as Politico and the Washington Post, the administration aims to issue guidance recommending that Tylenol be used by pregnant women only when necessary, especially for reducing high fevers. At the same time, the experimental use of leucovorin a form of folinic acid will also be presented. Some studies have shown that leucovorin may provide modest improvements in cognitive and communication functions in children with autism spectrum disorders.

However, the scientific community remains divided. So far, there is no clear and conclusive evidence proving that the use of acetaminophen during pregnancy causes autism. Although some epidemiological studies have suggested a slight increase in risk, these results are often influenced by external factors such as genetic predisposition, the mother’s health, and environmental conditions.

Many reputable medical institutions, including the American College of Obstetricians and Gynecologists, have emphasized that careful use of Tylenol is safe during pregnancy, particularly when managing high fevers that could have dangerous consequences for fetal development.

“KORÇA BOOM”